hai The adaptive immune system Conferences | Meetings | Events | Symposiums | ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for The adaptive immune system

The adaptive immune system


As per available reports about 50 open access articles, 11 Scientific conferences, 7 national symposiums are presently dedicated exclusively to adaptive immune system and about 6 speakers gave presentations on adaptive immune system.

The adaptive immune system, also known as the acquired immunity or, more rarely, as the specific immune system, is a subsystem of the overall immune system that is composed of highly specialized, systemic cells and processes that eliminate or prevent pathogen growth. One of the two main immunity strategies found in vertebrates (the other being the innate immune system), acquired immunity creates immunological memory after an initial response to a specific pathogen, leading to an enhanced response to subsequent encounters with that same pathogen. This process of acquired immunity is the basis of vaccination. Like the innate system, the adaptive system includes both humoral immunity components and cell-mediated immunity components. Unlike, innate immunity, adaptive immunity are highly specific to a specific pathogen. Adaptive immunity can also provide long-lasting protection: for example; someone who recovers from measles is now protected against measles for their lifetime but in other cases it does not provide a life time protection: for example; chickenpox. The adaptive system response destroys invading pathogens and any toxic molecules they produce. Sometimes the adaptive system is unable to distinguish foreign molecules, the effects of this may be hayfever, asthma or any other allergies. Antigens are any subtances that elicit the adaptive immune response. The ones in charged to carry the adaptive immune response are the white blood cells also known as lymphocytes. There are two main broad classes- antibody responses and cell mediated immune response which are also carried by two different lymphocytes (B cells and T cells). In antibody responses, B cells are activated to secrete antibodies, which are proteins and are also known as immunoglobulins. Antibodies travel through the bloodstream and then bind to the foreign antigen causing it to inactivate in which does not allow the antigen to bind to the host. In acquired immunity, pathogen-specific receptors are "acquired" during the lifetime of the organism (whereas in innate immunity pathogen-specific receptors are already encoded in the germline). The acquired response is said to be "adaptive" because it prepares the body's immune system for future challenges (though it can actually also be maladaptive when it results in autoimmunity).
 

OMICS International 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies  and Publishes 700+ Open access journals Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017 at a compound annual growth rate (CAGR) of 5.3%.An overview of the global market for human and animal (veterinary) vaccines and related vaccine technologies. Analyses of global market trends, with data from 2010, 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017. Examination of current and future strategies within the human and animal (veterinary) vaccines markets, including attenuated (live) vaccines, inactivated (killed) vaccines, conjugate vaccines, recombinant/recombinant DNA (rDNA) vaccines, subunit vaccines, toxoid vaccines, and combination vaccines. A breakdown of the seven major categories of vaccines broken down by market shares belonging to leading manufacturers and/or suppliers. Discussion of human and animal (veterinary) vaccines as to their prophylactic or therapeutic use, with emphasis in the meningococcal/pneumococcal vaccines, influenza vaccines, pediatric vaccines, adult/adolescent vaccines, and travel vaccines.

List of Relevant Conferences:

  • Protein Engineering Conference October 26-28, 2015 Chicago, USA
  • Vaccines Middle East Conference September 28-30, 2015 Dubai, UAE
  • Vaccines Asia Pacific Conference November 10-12, 2016 Melbourne, Australia
  • Global Vaccines Conference                                                                             November 30-December 02, 2015 San Francisco, USA
  • Euro Vaccines Conference June 16-18, 2016 Rome, Italy
  • Hepatitis Vaccines Conference June 16-18, 2016 Rome, Italy
  • Hiv Vaccines Conference Oct 3-5, 2016 Miami, USA
  • Proteomics Conference September 01-03, 2015 Valencia, Spain
  • World Proteomics Conference March 29-30, 2016 Atlanta, USA
  • 2015 IMMUNIZATION SUMMIT! NAMPA, IDAHO MONDAY, SEPTEMBER 21, 2015
  • 14th Annual Measles and Rubella Initiative Meeting: Focusing on the Human and Financial Costs of Measles Washington, USA September 15-16, 2015
  • 19th Annual Conference on Vaccine Research April 18-20, 2016 Baltimore, USA
  • Clinical Vaccinology Course Bethesda, MD November 13, 2015
  • 9th Vaccine & ISV Congress                                                                              18-20 October 2015 | Lotte Hotel, Seoul, South Korea
  • 2016 North Dakota State Immunization Conference                                           August 3-4, 2016, Bismarck, ND

Relevant societies and associations:

  • Immunization Action Coalition
  • The International Society for Vaccines
  • Center for Knowledge Societies
  • Biobanking and BioMolecular resources Research Infrastructure — European Research Infrastructure Consortium (BBMRI-ERIC)
  • Applied Research on Cancer (ARC-NET)
  • European, Middle Eastern & African Society for Biopreservation & Biobanking (ESBB)
  • The network of National Cancer Institutions of Latin America (RINC)
  • American Cancer Society
  • African Organization for Research & Training in Cancer (AORTIC)
  • GAVI, THE VACCINE ALLIANCE
  • Centre of Genomics and Policy (CGP)

Relevant Companies:

  • Vaccine Delivery Innovation Initiative
  • Four Seasons Pharmacy
  • Dubai Health authority
  • pfizer
  • Sanofi
  • GlaxoSmithKline
  • Novartis
  • MSD
  • Antivenom & vaccine Production centre
  • The centre for food security &public Health
  • National Institute of Agrobiological SciencesGenebank
  • Merck

This page will be updated regularly.

This page was last updated on November 5, 2024

Conference Series Destinations